JAG1 — Jagged 1

📖 Wiki Page

gene1775 wordssynced 2026-04-02

JAG1 — Jagged 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">JAG1 — Jagged 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>JAG1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Jagged 1 (Notch Ligand)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>20p12.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1950" target="_blank">1950</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000101384" target="_blank">ENSG00000101384</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/184756" target="_blank">184756</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P78504" target="_blank">P78504</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,218 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~134 kDa</td></tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), Alagille Syndrome, Deafness</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cerebral [cortex](/brain-regions/cortex), Cochlea, Liver, Heart</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color

...

JAG1 — Jagged 1

Overview

JAG1 (Jagged 1), also known as CD339, is a critical member of the Notch ligand family that plays essential roles in cell fate determination, embryonic development, tissue homeostasis, and increasingly recognized functions in neurodegeneration. Located on chromosome 20p12.2, this gene encodes a 1,218-amino acid transmembrane protein that serves as a ligand for Notch receptors (NOTCH1-4), triggering canonical Notch signaling cascades that influence gene expression programs throughout development and adult life[^berezov2012].

The JAG1-Notch axis has garnered significant attention in neurodegeneration research due to its involvement in Alzheimer's disease pathogenesis, neurogenesis regulation, neuroinflammation, and synaptic plasticity. Elevated JAG1 expression has been documented in Alzheimer's disease brains, and the protein interfaces with amyloid-beta pathology, tau pathology, and neuronal survival pathways. Beyond AD, JAG1 has relevance to other neurodegenerative conditions and developmental disorders, making it a significant node at the intersection of developmental biology and age-related neurodegeneration[@lau2020][^lau2020].

Gene and Protein Structure

Gene Organization

| Feature | Details |
|---------|---------|
| Gene Symbol | JAG1 (CD339, JAG1, Serrate-1) |
| Full Name | Jagged 1 |
| Chromosomal Location | 20p12.2 |
| NCBI Gene ID | 1950 |
| OMIM | 184756 |
| Ensembl ID | ENSG00000101384 |
| UniProt | P78504 |
| Protein Length | 1,218 amino acids |
| Molecular Weight | ~134 kDa |

Protein Domain Architecture

JAG1 is a type I transmembrane protein with complex domain organization:

N-terminal signal peptide (aa 1-20): Directs protein to secretory pathway

DSL domain (aa 45-100): Delta-Serrate-Lag domain critical for Notch binding

Multiple EGF-like repeats (aa 100-650): 16 EGF-like repeats mediating receptor interaction specificity

Cysteine-rich region (aa 650-800): Maintains proper protein folding

Transmembrane domain (aa 800-825): Single pass membrane anchor

Cytoplasmic tail (aa 825-1218): Intracellular signaling functions

The extracellular domain undergoes proteolytic cleavage (S1 cleavage) to produce a soluble form, and the remaining membrane-bound fragment can undergo S2 cleavage by ADAM proteases to release the intracellular domain (NICD) for nuclear signaling.

Alternative Splicing

Multiple JAG1 isoforms have been described:

Full-length transmembrane isoform (canonical)
Soluble isoforms generated by alternative splicing or proteolysis
Cell-type specific isoforms with distinct signaling properties

Biological Functions

Notch Receptor Activation

JAG1 activates Notch receptors through cell-cell contact:

Mermaid diagram (expand to render)

Notch Receptor Family:

NOTCH1: Ubiquitous expression, diverse functions
NOTCH2: Brain, immune system
NOTCH3: Vascular smooth muscle, CNS
NOTCH4: Endothelial cells

Key Signaling Pathways

Canonical Notch Signaling:

JAG1 binds Notch receptor on adjacent cell

S2 cleavage releases extracellular fragment

S3 cleavage (γ-secretase) releases NICD

NICD translocates to nucleus

Forms complex with CSL (RBPJ) and co-activators

Transcribes Hes, Hey, and other target genes

Non-canonical Pathways:

Notch interactions with other receptors
JAG1-independent Notch activation
Cross-talk with Wnt, Hedgehog, BMP pathways

Role in Neurodegeneration

Alzheimer's Disease

JAG1 has emerged as a significant player in AD pathogenesis[@chen2023][^berezov2012][^chen2023]:

1. Amyloid-Beta Interaction

JAG1 expression elevated in AD brain
Aβ enhances JAG1 expression in neurons and glia
JAG1-Notch signaling intersects with APP processing
NICD generation modified by Aβ exposure

2. Tau Pathology

Notch signaling affects tau phosphorylation
JAG1 modulates tau-related gene expression
Potential cross-talk in neurofibrillary tangle formation

3. Neuroinflammation

JAG1 in microglial activation
Notch-mediated cytokine production
Neuroinflammatory amplification loop[^song2022]

4.[@song2022] Synaptic Dysfunction

Notch regulates synaptic plasticity genes
JAG1-Notch affects LTP and memory formation
Contributes to early synaptic deficits

5. Neurogenesis Impact

Adult hippocampal neurogenesis impaired in AD
JAG1-Notch affects neural stem cell fate
Links to cognitive decline

Parkinson's Disease

Though less studied, JAG1 has relevance to PD:

1. Dopaminergic Development

Notch signaling in dopaminergic neuron specification
JAG1 expression in substantia nigra
May affect neuronal survival

2. Alpha-Synuclein Pathology

Notch activation influences α-synuclein aggregation
Potential cross-talk in synucleinopathy
Neuronal vulnerability modulation

3. Neuroinflammation

Microglial Notch signaling in PD
JAG1 in inflammatory responses

Amyotrophic Lateral Sclerosis

In ALS, JAG1 contributes through:

1. Motor Neuron Development

Notch in motor neuron specification
Altered JAG1 expression in ALS
Developmental vulnerability

2. Glial-Neuronal Communication

Astrocytic JAG1 affecting motor neurons
Non-cell autonomous toxicity
Notch-mediated signaling inglia

Other Neurodegenerative Conditions

Huntington's Disease: Notch in striatal neuron function
Multiple Sclerosis: JAG1 in demyelination
Stroke: Notch in ischemia response

Expression Patterns

Brain Regional Distribution

| Brain Region | Expression Level | Notes |
|-------------|-----------------|-------|
| Hippocampus | High | CA1-CA3, dentate gyrus |
| Cerebral Cortex | High | Layer 5 pyramidal neurons |
| Subventricular Zone | High | Neural stem cells |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Cerebellum | Moderate | Purkinje cells |

Cell-Type Specificity

Neurons: High expression, particularly pyramidal neurons
Astrocytes: Moderate, increases with activation
Microglia: Inducible expression under stress
Oligodendrocytes: Lower expression
Neural Stem Cells: High for fate decisions

Non-CNS Expression

JAG1 is widely expressed outside the CNS:

Cochlea: Inner ear development, deafness in Alagille
Vascular system: Angiogenesis
Liver: Bile duct development
Heart: Valve formation

Interaction Network

Notch Receptors

| Receptor | Interaction | Primary Functions |
|----------|-------------|-------------------|
| NOTCH1 | Primary | Diverse, ubiquitous |
| NOTCH2 | Strong | Brain, immune |
| NOTCH3 | Moderate | Vascular, CNS |
| NOTCH4 | Weaker | Endothelial |

Co-factors and Modulators

DLL ligands: JAG1 co-operates with DLL1, DLL4
Fringe proteins: Modify JAG1-Notch specificity
ADAM proteases: S2 cleavage (TACE/ADAM17)
γ-secretase: S3 cleavage (presenilins)

Downstream Targets

HES/HEY Family:

HES1, HES5: Master regulators
HEY1, HEY2: Cardiovascular, neuronal

Other Targets:

Cyclin D1 (cell cycle)
c-Myc (proliferation)
NF-κB components
Notch1 itself (feedback)

Therapeutic Implications

Therapeutic Target Rationale

Modulating JAG1-Notch offers therapeutic potential[^chen2023]:

1. γ-Secretase Inhibitors

Prevent NICD generation
Clinical trials in AD (failed, too broad)
Next-gen selective inhibitors

2. Notch Receptor Modulators

Monoclonal antibodies against Notch
Engineered decoy receptors
Small molecule modulators

3. JAG1-Specific Approaches

JAG1 neutralizing antibodies
Peptide blockers of JAG1-Notch interaction
Soluble JAG1 for pathway modulation

Challenges

Developmental toxicity: Notch inhibition affects many processes
Bidirectional effects: Both protective and pathogenic roles
Selectivity: JAG1 vs. other ligands
CNS delivery: Blood-brain barrier challenges

Preclinical Approaches

Antibody-based therapies
Small molecule γ-secretase modulators
Natural compounds affecting Notch
Gene therapy targeting JAG1

Genetic Variants

Disease-Associated Variants

Alagille Syndrome: ~40% caused by JAG1 mutations
Tetralogy of Fallot: Associated variants
Deafness: Cochlear expression variants

Alzheimer's Disease

No strong AD-associated JAG1 variants
Expression quantitative trait loci (eQTLs)
Potential modifier effects

Research Directions

Key Questions

How does JAG1-Notch specifically contribute to AD vs. normal aging?

What determines protective vs. pathogenic signaling?

Can selective modulation avoid developmental toxicity?

Are there therapeutic windows for intervention?

Emerging Research

Single-cell Notch pathway analysis
Structure-based inhibitor design
Brain-penetrant Notch modulators
Combination with anti-Aβ therapies

External Links

[NCBI Gene: JAG1](https://www.ncbi.nlm.nih.gov/gene/1950)
[UniProt: JAG1](https://www.uniprot.org/uniprot/P78504)
[Ensembl: JAG1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000101384)
[OMIM: JAG1](https://www.omim.org/entry/184756)

References

[Berezov A, et al., Jagged1 in Alzheimer's disease. Curr Alzheimer Res. 2012](https://pubmed.ncbi.nlm.nih.gov/23172756/)

[Lau Y, et al., Notch ligand expression in neurodegeneration. J Mol Neurosci. 2020](https://pubmed.ncbi.nlm.nih.gov/32289234/)

[Ables JL, et al., Notch signaling in neural stem cells and neurodegeneration. Nat Rev Neurosci. 2021](https://pubmed.ncbi.nlm.nih.gov/34117420/)

[Song W, et al., JAG1/Notch in amyloid-beta toxicity and neuroinflammation. Cell Rep. 2022](https://pubmed.ncbi.nlm.nih.gov/35697654/)

[Chen J, et al., Targeting Notch signaling in Alzheimer's disease therapy. Pharmacol Ther. 2023](https://pubmed.ncbi.nlm.nih.gov/36984752/)

Mechanistic Pathway: JAG1-Notch in Alzheimer's Disease

Mermaid diagram (expand to render)

Notch Pathway in Neurobiology

Neurogenesis and Neural Stem Cells

Notch signaling maintains neural stem cell pools:

Lateral inhibition: Differentiating neurons inhibit neighbors
Self-renewal: Notch promotes stem cell maintenance
Astrocyte vs. neuron fate: Notch influences differentiation

Synaptic Plasticity

Notch contributes to learning and memory:

LTP modulation: Notch affects synaptic strengthening
Memory formation: Notch target genes in hippocampus
Cognitive function: Notch dysregulation impairs cognition

Glial Development

Oligodendrocyte differentiation regulated by Notch
Astrocyte fate specification
Microglial activation states

Cross-Talk with Other Pathways

| Pathway | Interaction | Outcome |
|---------|-------------|---------|
| APP/Aβ | Bidirectional | JAG1 affects APP, Aβ affects Notch |
| Tau | Phosphorylation | Notch affects kinases/phosphatases |
| Neuroinflammation | NF-κB | Notch and NF-κB cross-talk |
| Wnt | Transcriptional | Convergence on common targets |
| BMP | Receptor-level | Competition/modulation |

Cell-Cell Communication

JAG1-mediated Notch signaling is unique:

Requires direct cell-cell contact
Forms communication channels
Coordinates tissue-level decisions

Biomarker Development

Expression Biomarkers

JAG1 mRNA in blood cells
Soluble JAG1 in CSF
Notch target genes as readouts

Clinical Applications

Disease progression markers
Therapeutic response monitoring
Patient stratification

Aging and Notch

Declining Notch activity with age
Reduced neurogenesis in aging
Increased JAG1 in pathological aging
Therapeutic window for modulation

Animal Models

Genetic Models

Knockout mice: embryonic lethal
Conditional deletion in CNS
Transgenic overexpression
Humanized models

Phenotypic Analysis

Learning and memory tests
Neurogenesis assessment
Amyloid and tau pathology
Electrophysiology

Research Directions and Unanswered Questions

Critical Knowledge Gaps

Cell-type specific roles of JAG1 in AD

JAG1 vs. other Notch ligands in neurodegeneration

Optimal intervention point in the pathway

Biomarkers for therapeutic development

Emerging Areas

Cryo-EM structures of JAG1-Notch complexes
Single-cell pathway analysis
Brain-penetrant modulators
Gene therapy approaches

Pathway Diagram

The following diagram shows the key molecular relationships involving JAG1 — Jagged 1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

JAG1 — Jagged 1

JAG1 — Jagged 1

JAG1 — Jagged 1

JAG1 — Jagged 1

Overview

Gene and Protein Structure

Gene Organization

Protein Domain Architecture

Alternative Splicing

Biological Functions

Notch Receptor Activation

Key Signaling Pathways

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Other Neurodegenerative Conditions

Expression Patterns

Brain Regional Distribution

Cell-Type Specificity

Non-CNS Expression

Interaction Network

Notch Receptors

Co-factors and Modulators

Downstream Targets

Therapeutic Implications

Therapeutic Target Rationale

Challenges

Preclinical Approaches

Genetic Variants

Disease-Associated Variants

Alzheimer's Disease

Research Directions

Key Questions

Emerging Research

See Also

External Links

References

Mechanistic Pathway: JAG1-Notch in Alzheimer's Disease

Notch Pathway in Neurobiology

Neurogenesis and Neural Stem Cells

Synaptic Plasticity

Glial Development

Cross-Talk with Other Pathways

Interactions with AD-Related Pathways

Cell-Cell Communication

Biomarker Development

Expression Biomarkers

Clinical Applications

Age-Related Changes

Aging and Notch

Animal Models

Genetic Models

Phenotypic Analysis

Research Directions and Unanswered Questions

Critical Knowledge Gaps

Emerging Areas

Pathway Diagram